Baraclude and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Baraclude (entecavir), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Amlodipine, and have Blood pressure abnormal.

The phase IV clinical study analyzes which people have Stroke when taking Baraclude. It is created by eHealthMe based on reports of 6,115 people who have side effects when taking Baraclude from the FDA, and is updated regularly.

What is Baraclude?

Baraclude has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 6,175 Baraclude users. Check the latest studies of Baraclude.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,355 drugs and 3,022 conditions by eHealthMe. Check the latest studies of Stroke.

On Mar, 18, 2026

6,115 people reported to have side effects when taking Baraclude.
Among them, 29 people (0.47%) have Stroke.

Among these 29 people:

How long have people been on Baraclude when they have Stroke? *

What is the gender of people who have Stroke when taking Baraclude? *

female: 35.71 %
male: 64.29 %

What is the age of people who have Stroke when taking Baraclude? *

What are other drugs people take besides Baraclude? *

What are other side effects people have besides Stroke? *

Back Pain: 4 people, 13.79%
Post Herpetic Neuralgia (neuralgia caused by the varicella zoster virus): 4 people, 13.79%
Herpes Zoster: 4 people, 13.79%
Gait Disturbance: 4 people, 13.79%
Gastroenteritis Viral (inflammation of stomach and intestine caused by virus infection): 3 people, 10.34%
Abdominal Discomfort: 3 people, 10.34%
Dehydration (dryness resulting from the removal of water): 3 people, 10.34%
Nausea And Vomiting: 3 people, 10.34%
Swallowing Difficulty: 2 people, 6.90%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 3.45%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 13.79%
Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 4 people, 13.79%
High Blood Cholesterol: 4 people, 13.79%
Blood Pressure Abnormal: 4 people, 13.79%
Immune System Disorder: 3 people, 10.34%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 3.45%
Multiple Myeloma (cancer of the plasma cells): 1 person, 3.45%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 3.45%
Hepatocellular Carcinoma (liver cancer): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Baraclude and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Baraclude:

Baraclude (6,175 reports)

Stroke treatments and more:

Stroke (334,634 reports)

Browse all side effects of Baraclude:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,355 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,022 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on entecavir (the active ingredients of Baraclude) and Baraclude (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.